Ad Campaign Fuels Debate On Breast-Cancer Gene Test
By Marilyn Chase,
Wall Street Journal
| 09. 11. 2007
A new direct-to-consumer ad campaign for a breast-cancer gene test is reigniting a debate over who really needs the test and whether it will induce low-risk women to take drastic measures to prevent the disease.
At issue is a series of ads to promote Myriad Genetics Inc.'s test for so-called BRCA 1 and BRCA 2 gene mutations. The mutations, while rare, signal a high risk of developing breast or ovarian cancer in affected women. Women who find they carry the mutations often take steps to lessen their risk. That can mean more frequent screenings and taking certain preventive drugs, but also can include prophylactic surgical removal of a woman's breasts or ovaries.
The gene tests aren't foolproof, however. And some experts worry that a campaign calling attention to a rare condition could create unnecessary fear -- sending thousands of healthy women with no family history of cancer into the doctor's office demanding tests that won't help them. Or lead others to a false sense of security about their results.
"Marketing has the capacity to raise public awareness -- a good...
Related Articles
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Carey Gillan, UnSpun | 03.18.2024
A Mexican standoff with the United States turned into a Mexican smack-down this month with the release of Mexico’s formal rebuttal to US efforts to overturn limits Mexico has ordered on the use of genetically modified (GM) corn and the...